Neurointerventionalist and Patient Radiation Doses in Endovascular Treatment of Acute Ischemic Stroke.


Journal

Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 22 10 2019
accepted: 08 01 2020
pubmed: 25 1 2020
medline: 21 10 2020
entrez: 25 1 2020
Statut: ppublish

Résumé

To evaluate the patient and the neurointerventionalist radiation dose levels during endovascular treatment of acute ischemic stroke, and to analyze factors affecting doses. From October 2017 to January 2019, we prospectively collected patient radiation data and neurointerventionalist data from real-time dosimetry from all consecutive thrombectomies. Multivariate analysis was performed to analyze patient total dose area product (DAP) and neurointerventionalist dose variability in terms of clinical characteristics and the technical parameters of thrombectomies. Local dose reference levels (RL) were derived as the 75th percentile of the patient dose distributions. A total of 179 patients were treated during the study period and included in this study. Local dose RL for thrombectomy was derived for total DAP to 34 Gy cm New reference patient doses lower than those in previously published studies were defined. However, the operator's doses were higher than those in the only available study reporting on operator's dose during cerebral interventions.

Identifiants

pubmed: 31974745
doi: 10.1007/s00270-020-02412-w
pii: 10.1007/s00270-020-02412-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-612

Auteurs

Andrej Klepanec (A)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.
University of Ss. Cyril and Methodius in Trnava, Namestie J. Herdu 2, 917 01, Trnava, Slovakia.

Dusan Salat (D)

University of Ss. Cyril and Methodius in Trnava, Namestie J. Herdu 2, 917 01, Trnava, Slovakia.

Jan Harsany (J)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.

Matus Hoferica (M)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.

Georgi Krastev (G)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.

Jozef Haring (J)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.

Miroslav Mako (M)

University Hospital Trnava, A. Zarnova 11, 917 75, Trnava, Slovakia.

Pavol Janega (P)

Faculty of Medicine, Comenius University in Bratislava, Špitálska 24, 813 72, Bratislava, Slovakia.

Lenka Janosikova (L)

University of Ss. Cyril and Methodius in Trnava, Namestie J. Herdu 2, 917 01, Trnava, Slovakia.

Viera Lehotska (V)

Faculty of Medicine, Comenius University in Bratislava, Heydukova 10, 812 50, Bratislava, Slovakia. viera.lehotska@ousa.sk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH